Discovery may bring special treatment for male babies

Mar 25, 2008

Hunter researchers have discovered that male babies born prematurely are more vulnerable to cardiovascular complications than female babies.

This finding may explain why male babies born prematurely are twice as likely to die as female babies in the first 72 hours of life. It could also lead to new ways of treating premature babies throughout the world.

Researchers from Hunter New England Health and the University of Newcastle, in collaboration with the Hunter Medical Research Institute’s Pregnancy and Reproduction Research Program, completed two studies, looking at babies born at 24 weeks to full term.

“This is the first time that the small blood vessels (microvasculature) have been extensively studied in a large group of premature babies,” said Dr Ian Wright, a Neonatologist at Hunter New England Health’s Kaleidoscope Neonatal Intensive Care Unit.

“We discovered that changes in small blood vessels are linked with how sick the babies are after birth. Babies who had low blood pressure and were more ill were unable to control the blood flow in their small blood vessels. This was less of a problem as babies got older or if they were born more mature.

“We showed that there is a sex difference, with the girls able to regulate the small blood vessel flow, and boys unable to control it. Again, this difference resolved with time or was less of a problem in the more mature infants.

“The finding suggests that doctors may need to trial different approaches to treating baby boys, born prematurely, than baby girls. Earlier or more support for the circulation could be used

These findings were published in the journals Archives of Disease in Childhood, Fetal and Neonatal Edition and Pediatric Research. Infant mortality remains the most common cause of childhood death. Premature birth is the main cause of infant mortality and infant disability. In Australia, premature birth occurs in more than 17,000 pregnancies each year.

Source: Research Australia

Explore further: Clipping proteins that package genes may limit abnormal cell growth in tumors

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.